3/21
07:13 am
eton
Eton Pharmaceuticals (ETON) was upgraded by Zacks Research from "hold" to "strong-buy".
Medium
Report
Eton Pharmaceuticals (ETON) was upgraded by Zacks Research from "hold" to "strong-buy".
3/20
01:57 pm
eton
Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $37.00 to $52.00. They now have a "buy" rating on the stock.
Low
Report
Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $37.00 to $52.00. They now have a "buy" rating on the stock.
3/20
01:57 pm
eton
Eton Pharmaceuticals (ETON) had its price target raised by B. Riley Financial, Inc. from $26.00 to $31.00. They now have a "buy" rating on the stock.
Low
Report
Eton Pharmaceuticals (ETON) had its price target raised by B. Riley Financial, Inc. from $26.00 to $31.00. They now have a "buy" rating on the stock.
3/20
01:34 pm
eton
Eton Pharmaceuticals (ETON) had its price target raised by Craig Hallum from $30.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
Eton Pharmaceuticals (ETON) had its price target raised by Craig Hallum from $30.00 to $35.00. They now have a "buy" rating on the stock.
3/19
11:02 pm
eton
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
3/19
06:47 pm
eton
Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/19
06:46 pm
eton
Eton Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
3/19
04:55 pm
eton
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/19
04:10 pm
eton
Eton Pharmaceuticals Non-GAAP EPS of $0.19 misses by $0.01, revenue of $21.3M beats by $0.72M [Seeking Alpha]
High
Report
Eton Pharmaceuticals Non-GAAP EPS of $0.19 misses by $0.01, revenue of $21.3M beats by $0.72M [Seeking Alpha]
3/19
04:05 pm
eton
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
3/3
04:30 pm
eton
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Low
Report
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
3/3
09:51 am
eton
Eton Pharmaceuticals (ETON) had its price target raised by Craig Hallum from $29.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Eton Pharmaceuticals (ETON) had its price target raised by Craig Hallum from $29.00 to $30.00. They now have a "buy" rating on the stock.
3/2
08:03 am
eton
Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $35.00 to $37.00. They now have a "buy" rating on the stock.
Medium
Report
Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $35.00 to $37.00. They now have a "buy" rating on the stock.
3/2
08:01 am
eton
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution [Yahoo! Finance]
3/2
07:27 am
eton
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
Medium
Report
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
2/25
02:23 pm
eton
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution [Yahoo! Finance]
2/25
01:47 pm
eton
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
Low
Report
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
2/20
07:07 am
eton
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th [Yahoo! Finance]
2/20
06:50 am
eton
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
Low
Report
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
2/2
07:02 am
eton
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate [Yahoo! Finance]
Low
Report
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate [Yahoo! Finance]
2/2
06:50 am
eton
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
Low
Report
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
1/23
10:23 am
eton
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth [Seeking Alpha]
Low
Report
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth [Seeking Alpha]
1/3
05:42 am
eton
Eton Pharmaceuticals (NASDAQ:ETON) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Eton Pharmaceuticals (NASDAQ:ETON) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
1/2
12:50 am
eton
Those who invested in Eton Pharmaceuticals (NASDAQ:ETON) three years ago are up 483% [Yahoo! Finance]
Medium
Report
Those who invested in Eton Pharmaceuticals (NASDAQ:ETON) three years ago are up 483% [Yahoo! Finance]